Host-derived Bacillus megaterium BST-01 probiotic improves feed utilization, innate immunity against Streptococcus iniae infection, and gut microbiome shifts in Nile tilapia (Oreochromis niloticus)

Clinical Proteomics · Springer Nature · 2026-11-05 · DOI: 10.1007/s10499-026-02737-2

Аннотация

Probiotics are increasingly explored as sustainable alternatives to antibiotics in aquaculture. This study evaluated the probiotic potential of host-derived Bacillus megaterium BST-01 in Nile tilapia. BST-01 exhibited detectable protease, amylase, xylanase, and lipase activities, while disk-diffusion assays showed measurable inhibition zones for all tested antibiotics. Nile tilapia were fed diets supplemented with BST-01 at 10 5 , 10 6 , or 10 7 CFU g⁻ 1 for 8 weeks. Fish receiving 10 7 CFU g⁻ 1 showed improved growth performance, feed efficiency, intestinal amylase, cellulase, xylanase, and lipase activities, and altered hepatic expression of genes related to glucose metabolism and growth regulation. Prior to pathogen challenge, supplementation at 10 6 –10 7 CFU g⁻ 1 enhanced phagocytic activity, respiratory burst activity, lysozyme activity, and immune-related cytokine expression. Following Streptococcus iniae challenge, cumulative mortality was significantly reduced in the BM-6 and BM-7 groups compared with the challenged control. Gut microbiota analysis showed increased microbial richness and diversity, together with shifts in community composition characterized by reduced relative abundances of Aeromonas and Enterovibrio . Collectively, these findings support the potential of B. megaterium BST-01 as a host-derived probiotic for improving feed utilization, growth performance, innate immunity, disease resistance, and gut microbial composition in Nile tilapia.

Читать у издателя →

Похожие статьи